{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:24:03Z","timestamp":1791685443047,"version":"4.3.4"},"reference-count":112,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministry of Health of the Czech Republic","doi-asserted-by":"publisher","award":["15-30954A"],"award-info":[{"award-number":["15-30954A"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Defence","award":["17-05292S"],"award-info":[{"award-number":["17-05292S"]}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["CZ.02.1.01\/0.0\/0.0\/16_025\/0007444"],"award-info":[{"award-number":["CZ.02.1.01\/0.0\/0.0\/16_025\/0007444"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Direction G\u00e9n\u00e9rale de l\u2019Armement (DGA)"},{"name":"Service de Sant\u00e9 des Arm\u00e9es (SSA)","award":["PDH-2-NRBC-3-C-3201"],"award-info":[{"award-number":["PDH-2-NRBC-3-C-3201"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.ejmech.2019.02.021","type":"journal-article","created":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T21:43:27Z","timestamp":1551217407000},"page":"491-514","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":109,"special_numbering":"C","title":["Novel tacrine-tryptophan hybrids: Multi-target directed ligands as potential treatment for Alzheimer's disease"],"prefix":"10.1016","volume":"168","author":[{"given":"Katarina","family":"Chalupova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6977-7596","authenticated-orcid":false,"given":"Jan","family":"Korabecny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2890-3856","authenticated-orcid":false,"given":"Manuela","family":"Bartolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Monti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doriano","family":"Lamba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Caliandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Pesaresi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9219-1032","authenticated-orcid":false,"given":"Xavier","family":"Brazzolotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Julie","family":"Gastellier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0293-2429","authenticated-orcid":false,"given":"Florian","family":"Nachon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslav","family":"Pejchal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Jarosova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vendula","family":"Hepnarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Jun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Hrabinova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Dolezal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Zdarova Karasova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Mzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zdena","family":"Kristofikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Misik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubica","family":"Muckova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Jost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6376-8701","authenticated-orcid":false,"given":"Ondrej","family":"Soukup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marketa","family":"Benkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Setnicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Habartova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marketa","family":"Chvojkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenka","family":"Kleteckova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Vales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Mezeiova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Uliassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Valis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenie","family":"Nepovimova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1289-5361","authenticated-orcid":false,"given":"Maria Laura","family":"Bolognesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9664-1109","authenticated-orcid":false,"given":"Kamil","family":"Kuca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2019.02.021_bib1","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1021\/jm0340602","article-title":"3-(4-[[Benzyl(methyl)amino]methyl]phenyl)-6,7-dimethoxy-2H-2-chromenone (AP2238) inhibits both acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation: a dual function lead for Alzheimer's disease therapy","volume":"46","author":"Piazzi","year":"2003","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.021_bib2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1146\/annurev.publhealth.23.100901.140525","article-title":"The public health impact of Alzheimer's disease, 2000-2050: potential implication of treatment advances","volume":"23","author":"Sloane","year":"2002","journal-title":"Annu. Rev. Public Health"},{"key":"10.1016\/j.ejmech.2019.02.021_bib3","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.2174\/092986710791111206","article-title":"Tacrine derivatives and Alzheimer's disease","volume":"17","author":"Tumiatti","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.021_bib4","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S1474-4422(03)00502-7","article-title":"Treatment of Alzheimer's disease: current status and new perspectives","volume":"2","author":"Scarpini","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejmech.2019.02.021_bib5","doi-asserted-by":"crossref","first-page":"762","DOI":"10.2353\/ajpath.2008.080175","article-title":"Amyloid plaque and neurofibrillary tangle pathology in a regulatable mouse model of Alzheimer's disease","volume":"173","author":"Paulson","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejmech.2019.02.021_bib6","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer's disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2019.02.021_bib7","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","article-title":"Alzheimer's disease: genes, proteins, and therapy","volume":"81","author":"Selkoe","year":"2001","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejmech.2019.02.021_bib8","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1126\/science.7046051","article-title":"The cholinergic hypothesis of geriatric memory dysfunction","volume":"217","author":"Bartus","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2019.02.021_bib9","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.2174\/092986708785909067","article-title":"Acetylcholinesterase inhibitors as disease-modifying therapies for Alzheimer's disease","volume":"15","author":"Mu\u00f1oz-Torrero","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.021_bib10","first-page":"CD005593","article-title":"Cholinesterase inhibitors for Alzheimer's disease","author":"Birks","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejmech.2019.02.021_bib11","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0896-6273(00)80108-7","article-title":"Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme","volume":"16","author":"Inestrosa","year":"1996","journal-title":"Neuron"},{"key":"10.1016\/j.ejmech.2019.02.021_bib12","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1006\/jmbi.1997.1245","article-title":"Acetylcholinesterase promotes the aggregation of amyloid-beta-peptide fragments by forming a complex with the growing fibrils","volume":"272","author":"Alvarez","year":"1997","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.ejmech.2019.02.021_bib13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0014-5793(99)00468-8","article-title":"Neurotoxicity of acetylcholinesterase amyloid beta-peptide aggregates is dependent on the type of Abeta peptide and the AChE concentration present in the complexes","volume":"450","author":"Mu\u00f1oz","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejmech.2019.02.021_bib14","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1126\/science.1678899","article-title":"Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein","volume":"253","author":"Sussman","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2019.02.021_bib15","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1021\/bi201786s","article-title":"Reaction pathway and free energy profiles for butyrylcholinesterase-catalyzed hydrolysis of acetylthiocholine","volume":"51","author":"Chen","year":"2012","journal-title":"Biochemistry (Mosc.)"},{"issue":"Suppl 2","key":"10.1016\/j.ejmech.2019.02.021_bib16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00002093-199501002-00005","article-title":"Cholinesterases and the pathology of Alzheimer disease","volume":"9","author":"Geula","year":"1995","journal-title":"Alzheimers Dis. Assoc. Disord."},{"key":"10.1016\/j.ejmech.2019.02.021_bib17","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer's disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ejmech.2019.02.021_bib18","doi-asserted-by":"crossref","first-page":"11223","DOI":"10.1021\/bi991080q","article-title":"Are presenilins intramembrane-cleaving proteases? Implications for the molecular mechanism of Alzheimer's disease","volume":"38","author":"Wolfe","year":"1999","journal-title":"Biochemistry (Mosc.)."},{"key":"10.1016\/j.ejmech.2019.02.021_bib19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1089\/rej.2009.0958","article-title":"Beneficial catalytic immunity to abeta peptide","volume":"13","author":"Paul","year":"2010","journal-title":"Rejuvenation Res."},{"key":"10.1016\/j.ejmech.2019.02.021_bib20","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2019.02.021_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.npep.2015.06.008","article-title":"Amyloid cascade hypothesis: pathogenesis and therapeutic strategies in Alzheimer's disease","volume":"52","author":"Barage","year":"2015","journal-title":"Neuropeptides"},{"key":"10.1016\/j.ejmech.2019.02.021_bib22","first-page":"759","article-title":"Outcomes of Alzheimer's disease therapy with acetylcholinesterase inhibitors and memantine","volume":"13","author":"Zemek","year":"2014","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.ejmech.2019.02.021_bib23","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1124\/jpet.102.041616","article-title":"The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development","volume":"306","author":"Terry","year":"2003","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2019.02.021_bib24","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0140-6736(89)92246-0","article-title":"Long-term hepatotoxicity of tacrine","volume":"1","author":"Summers","year":"1989","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.ejmech.2019.02.021_bib25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3233\/JAD-2000-2204","article-title":"Tacrine (THA, Cognex(R))","volume":"2","author":"Summers","year":"2000","journal-title":"J.\u00a0Alzheimers Dis. JAD."},{"key":"10.1016\/j.ejmech.2019.02.021_bib26","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2174\/1567205011310080011","article-title":"A\u00a0resurrection of 7-MEOTA: a comparison with tacrine","volume":"10","author":"Soukup","year":"2013","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.ejmech.2019.02.021_bib27","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1021\/jm990971t","article-title":"SAR of 9-amino-1,2,3,4-tetrahydroacridine-based acetylcholinesterase inhibitors: synthesis, enzyme inhibitory activity, QSAR, and structure-based CoMFA of tacrine analogues","volume":"43","author":"Recanatini","year":"2000","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.021_bib28","doi-asserted-by":"crossref","first-page":"552","DOI":"10.2174\/1567205015666171212105412","article-title":"Cholinesterase inhibitor 6-chlorotacrine - in\u00a0vivo toxicological profile and behavioural effects","volume":"15","author":"Misik","year":"2018","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.ejmech.2019.02.021_bib29","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.2174\/1568026605666160927152728","article-title":"Multitarget tacrine hybrids with neuroprotective properties to confront Alzheimer's disease","volume":"17","author":"Spilovska","year":"2017","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.021_bib30","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.2174\/15680266113139990135","article-title":"The multifactorial nature of Alzheimer's disease for developing potential therapeutics","volume":"13","author":"Carreiras","year":"2013","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.021_bib31","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.2174\/1568026605666160927152728","article-title":"Multitarget tacrine hybrids with neuroprotective properties to confront Alzheimer's disease","volume":"17","author":"Spilovska","year":"2017","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.021_bib32","doi-asserted-by":"crossref","first-page":"953","DOI":"10.4155\/fmc-2017-0039","article-title":"Multitarget drug design strategy in Alzheimer's disease: focus on cholinergic transmission and amyloid-\u03b2 aggregation","volume":"9","author":"Simoni","year":"2017","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.021_bib33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40169-017-0181-2","article-title":"A\u00a0perspective on multi-target drug discovery and design for complex diseases","volume":"7","author":"Ramsay","year":"2018","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.ejmech.2019.02.021_bib34","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s12013-013-9707-4","article-title":"Neuroprotective effects of bis(7)-tacrine in a rat model of pressure-induced retinal ischemia","volume":"68","author":"Li","year":"2014","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.ejmech.2019.02.021_bib35","doi-asserted-by":"crossref","first-page":"23646","DOI":"10.1074\/jbc.271.39.23646","article-title":"Highly potent, selective, and low cost bis-tetrahydroaminacrine inhibitors of acetylcholinesterase. Steps toward novel drugs for treating Alzheimer's disease","volume":"271","author":"Pang","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2019.02.021_bib36","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1124\/mol.106.029108","article-title":"Synergistic neuroprotection by bis(7)-tacrine via concurrent blockade of N-methyl-D-aspartate receptors and neuronal nitric-oxide synthase","volume":"71","author":"Li","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.02.021_bib37","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.3233\/JAD-2004-6S610","article-title":"Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders","volume":"6","author":"Lipton","year":"2004","journal-title":"J.\u00a0Alzheimers Dis. JAD."},{"key":"10.1016\/j.ejmech.2019.02.021_bib38","doi-asserted-by":"crossref","first-page":"697","DOI":"10.4155\/fmc-2016-0003","article-title":"Multitarget strategies in Alzheimer's disease: benefits and challenges on the road to therapeutics","volume":"8","author":"Rosini","year":"2016","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.021_bib39","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2174\/0929867321666141106122628","article-title":"Recent development of multifunctional agents as potential drug candidates for the treatment of Alzheimer's disease","volume":"22","author":"Guzior","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.021_bib40","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/anie.201410456","article-title":"Multitarget drug discovery for Alzheimer's disease: triazinones as BACE-1 and GSK-3\u03b2 inhibitors","volume":"54","author":"Prati","year":"2015","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2019.02.021_bib41","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ejmech.2014.05.066","article-title":"7-MEOTA-donepezil like compounds as cholinesterase inhibitors: synthesis, pharmacological evaluation, molecular modeling and QSAR studies","volume":"82","author":"Korabecny","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.021_bib42","doi-asserted-by":"crossref","first-page":"7073","DOI":"10.1021\/jm5008648","article-title":"Synthesis and biological evaluation of novel tacrine derivatives and tacrine-coumarin hybrids as cholinesterase inhibitors","volume":"57","author":"Hamulakova","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.021_bib43","doi-asserted-by":"crossref","first-page":"6089","DOI":"10.1016\/j.bmc.2014.08.035","article-title":"Design, synthesis and evaluation of novel tacrine-(\u03b2-carboline) hybrids as multifunctional agents for the treatment of Alzheimer's disease","volume":"22","author":"Lan","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.021_bib44","doi-asserted-by":"crossref","first-page":"7223","DOI":"10.1021\/jm0503289","article-title":"Design, synthesis, and biological evaluation of dual binding site acetylcholinesterase inhibitors: new disease-modifying agents for Alzheimer's disease","volume":"48","author":"Mu\u00f1oz-Ruiz","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.021_bib45","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ejmech.2018.02.083","article-title":"The concept of hybrid molecules of tacrine and benzyl quinolone carboxylic acid (BQCA) as multifunctional agents for Alzheimer's disease","volume":"150","author":"Hepnarova","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.021_bib46","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1021\/jm050746d","article-title":"Novel tacrine-melatonin hybrids as dual-acting drugs for Alzheimer disease, with improved acetylcholinesterase inhibitory and antioxidant properties","volume":"49","author":"Rodr\u00edguez-Franco","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.021_bib47","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/cmdc.200800414","article-title":"Tacrine-melatonin hybrids as multifunctional agents for Alzheimer's disease, with cholinergic, antioxidant, and neuroprotective properties","volume":"4","author":"Fern\u00e1ndez-Bachiller","year":"2009","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2019.02.021_bib48","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1002\/prot.24080","article-title":"Generic inhibition of amyloidogenic proteins by two naphthoquinone-tryptophan hybrid molecules","volume":"80","author":"Scherzer-Attali","year":"2012","journal-title":"Proteins"},{"key":"10.1016\/j.ejmech.2019.02.021_bib49","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000448518","article-title":"Cl-NQTrp alleviates tauopathy symptoms in a model organism through the inhibition of tau aggregation-engendered toxicity","volume":"17","author":"Frenkel-Pinter","year":"2016","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.ejmech.2019.02.021_bib50","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.1016\/j.bmcl.2008.08.076","article-title":"Tacrine based human cholinesterase inhibitors: synthesis of peptidic-tethered derivatives and their effect on potency and selectivity","volume":"18","author":"Butini","year":"2008","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.02.021_bib51","doi-asserted-by":"crossref","first-page":"8576","DOI":"10.1021\/jm5010804","article-title":"Multitarget drug design strategy: quinone-tacrine hybrids designed to block amyloid-\u03b2 aggregation and to exert anticholinesterase and antioxidant effects","volume":"57","author":"Nepovimova","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.021_bib52","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00213-003-1632-6","article-title":"Effects of dietary tryptophan variations on extracellular serotonin in the dorsal hippocampus of rats","volume":"172","author":"van der Stelt","year":"2004","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.ejmech.2019.02.021_bib53","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1176\/appi.ajp.157.4.638","article-title":"Cognitive deficit induced by acute tryptophan depletion in patients with Alzheimer's disease","volume":"157","author":"Porter","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejmech.2019.02.021_bib54","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.bbr.2009.12.030","article-title":"Tryptophan depletion impairs object-recognition memory in the rat: reversal by risperidone","volume":"208","author":"Jenkins","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejmech.2019.02.021_bib55","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jmb.2005.04.016","article-title":"Prediction of \u201caggregation-prone\u201d and \u201caggregation-susceptible\u201d regions in proteins associated with neurodegenerative diseases","volume":"350","author":"Pawar","year":"2005","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.ejmech.2019.02.021_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011101","article-title":"Complete phenotypic recovery of an Alzheimer's disease model by a quinone-tryptophan hybrid aggregation inhibitor","volume":"5","author":"Scherzer-Attali","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2019.02.021_bib57","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1021\/cn400197x","article-title":"Atomic and dynamic insights into the beneficial effect of the 1,4-naphthoquinon-2-yl-L-tryptophan inhibitor on Alzheimer's A\u03b21-42 dimer in terms of aggregation and toxicity","volume":"5","author":"Zhang","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2019.02.021_bib58","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1021\/jm010308g","article-title":"Homodimeric tacrine congeners as acetylcholinesterase inhibitors","volume":"45","author":"Hu","year":"2002","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.021_bib59","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.3390\/molecules18022397","article-title":"7-Methoxytacrine-Adamantylamine heterodimers as cholinesterase inhibitors in Alzheimer's disease treatment \u2014 synthesis, biological evaluation and molecular modeling studies","volume":"18","author":"Spilovska","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2019.02.021_bib60","first-page":"22084","article-title":"7-Methoxytacrine-p-Anisidine hybrids as novel dual binding site acetylcholinesterase inhibitors for Alzheimer's disease treatment","volume":"20","author":"Korabecny","year":"2015","journal-title":"Mol. Basel Switz."},{"key":"10.1016\/j.ejmech.2019.02.021_bib61","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1039\/C39840001699","article-title":"Synthesis, properties, and use of Nin-Boc-tryptophan derivatives","author":"Franz\u00e9n","year":"1984","journal-title":"J.\u00a0Chem. Soc., Chem. Commun."},{"key":"10.1016\/j.ejmech.2019.02.021_bib62","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A\u00a0new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.02.021_bib63","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.talanta.2008.06.007","article-title":"Improvement of acetylcholinesterase-based assay for organophosphates in way of identification by reactivators","volume":"77","author":"Pohanka","year":"2008","journal-title":"Talanta"},{"key":"10.1016\/j.ejmech.2019.02.021_bib64","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1007\/s00044-015-1316-x","article-title":"Design, synthesis and in\u00a0vitro testing of 7-methoxytacrine-amantadine analogues: a novel cholinesterase inhibitors for the treatment of Alzheimer's disease","volume":"24","author":"Spilovska","year":"2015","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2019.02.021_bib65","doi-asserted-by":"crossref","first-page":"8985","DOI":"10.1021\/acs.jmedchem.5b01325","article-title":"Tacrine-trolox hybrids: a novel class of centrally active, nonhepatotoxic multi-target-directed ligands exerting anticholinesterase and antioxidant activities with low in\u00a0vivo toxicity","volume":"58","author":"Nepovimova","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.021_bib66","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ejmech.2016.12.048","article-title":"Tacrine-resveratrol fused hybrids as multi-target-directed ligands against Alzheimer's disease","volume":"127","author":"Je\u0159\u00e1bek","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.021_bib67","doi-asserted-by":"crossref","first-page":"10827","DOI":"10.1073\/pnas.89.22.10827","article-title":"Conversion of acetylcholinesterase to butyrylcholinesterase: modeling and mutagenesis","volume":"89","author":"Harel","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2019.02.021_bib68","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1021\/ja020850+","article-title":"Fundamental reaction mechanism for cocaine hydrolysis in human butyrylcholinesterase","volume":"125","author":"Zhan","year":"2003","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2019.02.021_bib69","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/1389557023406494","article-title":"Rational design of reversible acetylcholinesterase inhibitors","volume":"2","author":"Barril","year":"2002","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.021_bib70","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrn1035","article-title":"Neurobiology of butyrylcholinesterase","volume":"4","author":"Darvesh","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejmech.2019.02.021_bib71","doi-asserted-by":"crossref","first-page":"17213","DOI":"10.1073\/pnas.0508575102","article-title":"Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent","volume":"102","author":"Greig","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2019.02.021_bib72","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0026-895X(25)13975-8","article-title":"Propidium\u2014a fluorescence probe for a peripheral anionic site on acetylcholinesterase","volume":"10","author":"Taylor","year":"1974","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.02.021_bib73","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1021\/bi00680a029","article-title":"Interaction of fluorescence probes with acetylcholinesterase. The site and specificity of propidium binding","volume":"14","author":"Taylor","year":"1975","journal-title":"Biochemistry (Mosc.)"},{"key":"10.1016\/j.ejmech.2019.02.021_bib74","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S1357-2725(02)00027-4","article-title":"Inhibition of acetylcholinesterase from Electrophorus electricus (L.) by tricyclic antidepressants","volume":"34","author":"Nunes-Tavares","year":"2002","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ejmech.2019.02.021_bib75","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1021\/bi011652i","article-title":"3D structure of Torpedo californica acetylcholinesterase complexed with huprine X at 2.1 A resolution: kinetic and molecular dynamic correlates","volume":"41","author":"Dvir","year":"2002","journal-title":"Biochemistry (Mosc.)"},{"key":"10.1016\/j.ejmech.2019.02.021_bib76","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1021\/acs.jmedchem.5b01119","article-title":"Novel tacrine-benzofuran hybrids as potent multitarget-directed ligands for the treatment of Alzheimer's disease: design, synthesis, biological evaluation, and X-ray crystallography","volume":"59","author":"Zha","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.021_bib77","doi-asserted-by":"crossref","first-page":"4526","DOI":"10.1021\/ja058683b","article-title":"Conformational flexibility in the peripheral site of Torpedo californica acetylcholinesterase revealed by the complex structure with a bifunctional inhibitor","volume":"128","author":"Colletier","year":"2006","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2019.02.021_bib78","doi-asserted-by":"crossref","first-page":"9031","DOI":"10.1073\/pnas.90.19.9031","article-title":"Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase","volume":"90","author":"Harel","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2019.02.021_bib79","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.1021\/jm060164b","article-title":"Complexes of alkylene-linked tacrine dimers with Torpedo californica acetylcholinesterase: binding of Bis5-tacrine produces a dramatic rearrangement in the active-site gorge","volume":"49","author":"Rydberg","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.021_bib80","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0960-894X(00)80267-X","article-title":"Physical parameters for brian uptake: optimizing log P, log D and pKa of T H A","volume":"1","author":"Desai","year":"1991","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.02.021_bib81","doi-asserted-by":"crossref","first-page":"7753","DOI":"10.1021\/bi000210o","article-title":"Acetylthiocholine binds to asp74 at the peripheral site of human acetylcholinesterase as the first step in the catalytic pathway","volume":"39","author":"Mallender","year":"2000","journal-title":"Biochemistry (Mosc.)"},{"key":"10.1016\/j.ejmech.2019.02.021_bib82","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1126\/science.aao2825","article-title":"Fibril structure of amyloid-\u03b2(1-42) by cryo-electron microscopy","volume":"358","author":"Gremer","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2019.02.021_bib83","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jmb.2005.04.016","article-title":"Prediction of \u201caggregation-prone\u201d and \u201caggregation-susceptible\u201d regions in proteins associated with neurodegenerative diseases","volume":"350","author":"Pawar","year":"2005","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.ejmech.2019.02.021_bib84","doi-asserted-by":"crossref","first-page":"34156","DOI":"10.1074\/jbc.M102883200","article-title":"Analysis of the minimal amyloid-forming fragment of the islet amyloid polypeptide. An experimental support for the key role of the phenylalanine residue in amyloid formation","volume":"276","author":"Azriel","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2019.02.021_bib85","first-page":"77","article-title":"A\u00a0possible role for pi-stacking in the self-assembly of amyloid fibrils","volume":"16","author":"Gazit","year":"2002","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.ejmech.2019.02.021_bib86","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1073\/pnas.0406847102","article-title":"Molecular basis for amyloid fibril formation and stability","volume":"102","author":"Makin","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2019.02.021_bib87","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1002\/anie.200802123","article-title":"Cognitive-performance recovery of Alzheimer's disease model mice by modulation of early soluble amyloidal assemblies","volume":"48","author":"Frydman-Marom","year":"2009","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2019.02.021_bib88","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1002\/cbic.200700427","article-title":"Insight into the kinetic of amyloid beta (1-42) peptide self-aggregation: elucidation of inhibitors' mechanism of action","volume":"8","author":"Bartolini","year":"2007","journal-title":"Chembiochem Eur. J. Chem. Biol."},{"key":"10.1016\/j.ejmech.2019.02.021_bib89","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ab.2011.03.020","article-title":"Kinetic characterization of amyloid-beta 1-42 aggregation with a multimethodological approach","volume":"414","author":"Bartolini","year":"2011","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejmech.2019.02.021_bib90","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0006-2952(02)01514-9","article-title":"beta-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies","volume":"65","author":"Bartolini","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.02.021_bib91","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/S0002-9440(10)63774-1","article-title":"Acetylcholinesterase-Abeta complexes are more toxic than Abeta fibrils in rat hippocampus: effect on rat beta-amyloid aggregation, laminin expression, reactive astrocytosis, and neuronal cell loss","volume":"164","author":"Reyes","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejmech.2019.02.021_bib92","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1006\/bbrc.1997.6357","article-title":"A\u00a0monoclonal antibody against acetylcholinesterase inhibits the formation of amyloid fibrils induced by the enzyme","volume":"232","author":"Reyes","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2019.02.021_bib93","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1021\/jm070559a","article-title":"Novel class of quinone-bearing polyamines as multi-target-directed ligands to combat Alzheimer's disease","volume":"50","author":"Bolognesi","year":"2007","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.021_bib94","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/cmdc.201000086","article-title":"Bis(7)-tacrine derivatives as multitarget-directed ligands: focus on anticholinesterase and antiamyloid activities","volume":"5","author":"Bolognesi","year":"2010","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2019.02.021_bib95","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0223-5234(03)00012-6","article-title":"High throughput artificial membrane permeability assay for blood-brain barrier","volume":"38","author":"Di","year":"2003","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.021_bib96","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.ejmech.2015.12.024","article-title":"Cardanol-derived AChE inhibitors: towards the development of dual binding derivatives for Alzheimer's disease","volume":"108","author":"Lemes","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.021_bib97","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1021\/jm001020e","article-title":"High-throughput permeability pH profile and high-throughput alkane\/water log P with artificial membranes","volume":"44","author":"Wohnsland","year":"2001","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.021_bib98","series-title":"Assay Guid. Man.","article-title":"Cell viability assays","author":"Riss","year":"2004"},{"key":"10.1016\/j.ejmech.2019.02.021_bib99","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2174\/138920008784220619","article-title":"Possible role of hydroxylated metabolites of tacrine in drug toxicity and therapy of Alzheimer's disease","volume":"9","author":"Patocka","year":"2008","journal-title":"Curr. Drug Metabol."},{"key":"10.1016\/j.ejmech.2019.02.021_bib100","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.2174\/0929867323666160812151356","article-title":"An update on the role of nitric oxide in the neurodegenerative processes of Parkinson's disease","volume":"23","author":"Jim\u00e9nez-Jim\u00e9nez","year":"2016","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.021_bib101","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1111\/j.1460-9568.2006.04787.x","article-title":"Neuroprotective properties of memantine in different in\u00a0vitro and in\u00a0vivo models of excitotoxicity","volume":"23","author":"Volbracht","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejmech.2019.02.021_bib102","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1124\/mol.106.029108","article-title":"Synergistic neuroprotection by bis(7)-tacrine via concurrent blockade of N-methyl-D-aspartate receptors and neuronal nitric-oxide synthase","volume":"71","author":"Li","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.02.021_bib103","series-title":"7-MEOTA","first-page":"126","author":"Dejmek","year":"1990"},{"key":"10.1016\/j.ejmech.2019.02.021_bib104","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00213-011-2456-4","article-title":"The scopolamine model as a pharmacodynamic marker in early drug development","volume":"220","author":"Lenz","year":"2012","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.ejmech.2019.02.021_bib105","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0024-3205(95)02254-6","article-title":"Effects of tacrine (THA) on spatial reference memory and cholinergic enzymes in specific rat brain regions","volume":"58","author":"Jackson","year":"1996","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2019.02.021_bib106","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.lfs.2004.06.028","article-title":"The cholinesterase inhibitor, phenserine, improves Morris water maze performance of scopolamine-treated rats","volume":"76","author":"Janas","year":"2005","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2019.02.021_bib107","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1021\/jm901137j","article-title":"New substructure filters for removal of Pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays","volume":"53","author":"Baell","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.021_bib108","first-page":"104","article-title":"Kinetic analysis of amyloid fibril polymerization in\u00a0vitro","volume":"65","author":"Naiki","year":"1991","journal-title":"Lab. Investig. J. Tech. Methods Pathol."},{"key":"10.1016\/j.ejmech.2019.02.021_bib109","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/108705710100600309","article-title":"High throughput prediction of oral absorption: improvement of the composition of the lipid solution used in parallel artificial membrane permeation assay","volume":"6","author":"Sugano","year":"2001","journal-title":"J.\u00a0Biomol. Screen"},{"key":"10.1016\/j.ejmech.2019.02.021_bib110","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ab.2009.04.004","article-title":"A\u00a0cellular model for screening neuronal nitric oxide synthase inhibitors","volume":"390","author":"Fang","year":"2009","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejmech.2019.02.021_bib111","unstructured":"Guidance on Dose Level Selection for Regulatory General Toxicology Studies for Pharmaceuticals, (n.d.). https:\/\/www.norecopa.no\/3r-guide\/guidance-on-dose-level-selection-for-regulatory-general-toxicology-studies-for-pharmaceuticals (accessed June 22, 2018)."},{"key":"10.1016\/j.ejmech.2019.02.021_bib112","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.neulet.2016.06.034","article-title":"Cannula implantation into the lateral ventricle does not adversely affect recognition or spatial working memory","volume":"628","author":"Seyer","year":"2016","journal-title":"Neurosci. Lett."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419301357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419301357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:48:13Z","timestamp":1759326493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523419301357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":112,"alternative-id":["S0223523419301357"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.02.021","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel tacrine-tryptophan hybrids: Multi-target directed ligands as potential treatment for Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.02.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}